Defining medical cannabis with Myfanwy Graham
Addiction Audio5 Des 2025

Defining medical cannabis with Myfanwy Graham

In this episode, Dr Elle Wadsworth talks to Dr Myfanwy Graham, a Postgraduate Scholar at Monash University funded by the Australian Government's National Health and Medical Research Council. The interview covers Myfanwy’s data insight paper examining differences in the measurement of medical cannabis use.

  • Why definitions and contexts matter with regards to medical cannabis use [01:05]
  • Four measures of medical cannabis use that Myfanwy explored in the study [02:05]
  • The medical cannabis policy contexts of the US, Australia, and Canada [03:30]
  • The importance of using standardised questions across different countries [05:18]
  • The main findings of the data insight [05:48]
  • Interpretations of medical cannabis use [07:49]
  • The implications of the findings for policy and practice [08:23]
  • Myfanwy’s preferred measure of medical cannabis use [09:30]
  • Self perceptions of being a medical cannabis consumer [10:34]
  • The take-home messages of the study [11:56]


About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.

About Myfanwy Graham: Myfanwy is a Postgraduate Scholar funded by the Australian Government's National Health and Medical Research Council and a Monash Research Excellence Scholar at the Monash Addiction Research Centre, Monash University. Her research examines the intersection between drug policy and health outcomes with psychoactive medicines (e.g. medical cannabis, psychedelics). She is also a current Fellow at the Schaeffer Center for Health Policy and Economics at the University of Southern California and is a Fulbright Scholar Alumna in public health policy. Myfanwy has completed consultancy work for the Australian Government Department of Health, Disability and Ageing, World Health Organization, the United Nations Office on Drugs and Crime and the National Academies of Sciences, Engineering, and Medicine. She is also a registered pharmacist.

Authors have no conflicts of interest to declare.


Original article: Understanding medical cannabis use internationally: Why definitions and context matter https://doi.org/10.1111/add.70117


The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(126)

Opioids, cancer and mortality with Aleksi Hamina

Opioids, cancer and mortality with Aleksi Hamina

In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-a...

18 Jul 202413min

Cannabis potency and psychotic experiences with Lindsey Hines

Cannabis potency and psychotic experiences with Lindsey Hines

In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about...

6 Jun 202425min

Cannabis use in the US with Jonathan Caulkins

Cannabis use in the US with Jonathan Caulkins

In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same peri...

22 Mai 202422min

Integrated care vans with Kathleen Page

Integrated care vans with Kathleen Page

In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discu...

9 Mai 202426min

Smoking and abdominal obesity with Germán Carrasquilla

Smoking and abdominal obesity with Germán Carrasquilla

In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fa...

2 Mai 202417min

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They dis...

25 Apr 202423min

Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson

Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson

In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment setti...

17 Apr 202427min

Xylazine, heroin and drug markets with Caroline Copeland

Xylazine, heroin and drug markets with Caroline Copeland

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entere...

9 Apr 202420min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
villmarksliv
tidlose-historier
rss-overskuddsliv
rss-inn-til-kjernen-med-sunniva-rose
fjellsportpodden
nevropodden
nordnorsk-historie
kvinnehelsepodden
dekodet-2
rss-nysgjerrige-norge
rss-rekommandert